About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Efforts to modernize Medicare are once again gathering momentum in the nation’s capital. The current debate centers around cutting costs for patients, while also encouraging drug innovation, research and development. Should the government be able to negotiate drug prices in Medicare? What can Congress do to lower costs for prescription drugs for seniors and people with disabilities? Can Medicare be improved to help patients access care and afford their medications?
The Hill newspaper gathered policymakers, pharmaceutical company representatives and patient advocates to talk about updating Medicare to ensure its beneficiaries get the care they need and deserve.
When
July 27, 2021, 1:00 PM EST
Speakers:
- Lisa Joldersma, Senior Vice President, Policy, Research and Membership, PhRMA
- Luke Greenwalt, Vice President, IQVIA Market Access Center of Excellence
- Ruud Dobber, EVP & President BioPharmaceuticals Business Unit, AstraZeneca
- Randall Rutta, CEO, National Health Council
- Dr. Meena Seshamani, Deputy Administrator and Director, Center for Medicare at Centers for Medicare & Medicaid Services
Event
Medicare
Making Medicare Work Better for Patients
Making Medicare Work Better for Patients image